A continuation of the double-blind, placebo-controlled study to determine the safety and efficacy of long-term (3 years) lamivudine (LAI) in patients with chronic hepatitis B virus (HBV).


Grant Data
Project Title
A continuation of the double-blind, placebo-controlled study to determine the safety and efficacy of long-term (3 years) lamivudine (LAI) in patients with chronic hepatitis B virus (HBV).
Principal Investigator
Professor Lai, Ching Lung   (Principal investigator)
Co-Investigator(s)
Professor Wu Pui Chee   (Co-Investigator)
Duration
60
Start Date
1996-01-01
Completion Date
2000-12-31
Amount
0
Conference Title
Presentation Title
Grant Type
Other Funding Scheme
Funding Year
1995/1996
Status
Completed